Personalised reimbursement: a risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients

SBV van Doorn-Khosrovani; A Roy; L van Saase; M van der Graaff; J Gijzen; Stefan Sleijfer; LR Hoes; JMV Henegouwen; H van der Wijngaart; DL van der Velden; E van Werkhoven; VP Retel; WH Harten; ADR Huitema; L Timmers; H Gelderblom; HM Verheul; EE Voest

doi:10.1093/annonc/mdz119

Personalised reimbursement: a risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients

SBV van Doorn-Khosrovani, A Roy, L van Saase, M van der Graaff, J Gijzen, Stefan Sleijfer, LR Hoes, JMV Henegouwen, H van der Wijngaart, DL van der Velden, E van Werkhoven, VP Retel, WH Harten, ADR Huitema, L Timmers, H Gelderblom, HM Verheul, EE Voest

Medical Oncology

External organisation

Research output: Contribution to journal › Article › Academic › peer-review

30 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	663-665
Number of pages	3
Journal	Annals of Oncology
Volume	30
Issue number	5
DOIs	https://doi.org/10.1093/annonc/mdz119
Publication status	Published - 2019

Research programs

RSM LIS
EMC MM-03-86-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdz119

http://hdl.handle.net/1765/117379

Cite this

van Doorn-Khosrovani, SBV., Roy, A., van Saase, L., van der Graaff, M., Gijzen, J., Sleijfer, S., Hoes, LR., Henegouwen, JMV., van der Wijngaart, H., van der Velden, DL., van Werkhoven, E., Retel, VP., Harten, WH., Huitema, ADR., Timmers, L., Gelderblom, H., Verheul, HM., & Voest, EE. (2019). Personalised reimbursement: a risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients. Annals of Oncology, 30(5), 663-665. https://doi.org/10.1093/annonc/mdz119

@article{409f0cceba6e4900b42526446b817b7a,

title = "Personalised reimbursement: a risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients",

author = "\{van Doorn-Khosrovani\}, SBV and A Roy and \{van Saase\}, L and \{van der Graaff\}, M and J Gijzen and Stefan Sleijfer and LR Hoes and JMV Henegouwen and \{van der Wijngaart\}, H and \{van der Velden\}, DL and \{van Werkhoven\}, E and VP Retel and WH Harten and ADR Huitema and L Timmers and H Gelderblom and HM Verheul and EE Voest",

year = "2019",

doi = "10.1093/annonc/mdz119",

language = "Undefined/Unknown",

volume = "30",

pages = "663--665",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

number = "5",

}

van Doorn-Khosrovani, SBV, Roy, A, van Saase, L, van der Graaff, M, Gijzen, J, Sleijfer, S, Hoes, LR, Henegouwen, JMV, van der Wijngaart, H, van der Velden, DL, van Werkhoven, E, Retel, VP, Harten, WH, Huitema, ADR, Timmers, L, Gelderblom, H, Verheul, HM & Voest, EE 2019, 'Personalised reimbursement: a risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients', Annals of Oncology, vol. 30, no. 5, pp. 663-665. https://doi.org/10.1093/annonc/mdz119

TY - JOUR

T1 - Personalised reimbursement: a risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients

AU - van Doorn-Khosrovani, SBV

AU - Roy, A

AU - van Saase, L

AU - van der Graaff, M

AU - Gijzen, J

AU - Sleijfer, Stefan

AU - Hoes, LR

AU - Henegouwen, JMV

AU - van der Wijngaart, H

AU - van der Velden, DL

AU - van Werkhoven, E

AU - Retel, VP

AU - Harten, WH

AU - Huitema, ADR

AU - Timmers, L

AU - Gelderblom, H

AU - Verheul, HM

AU - Voest, EE

PY - 2019

Y1 - 2019

U2 - 10.1093/annonc/mdz119

DO - 10.1093/annonc/mdz119

M3 - Article

C2 - 31038154

SN - 0923-7534

VL - 30

SP - 663

EP - 665

JO - Annals of Oncology

JF - Annals of Oncology

IS - 5

ER -